EMEA-002905-PIP01-20-M01

EMEA-003133-PIP01-21-M01

EMEA-003174-PIP01-21-M02

EMEA-003426-PIP01-23-M02

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Human medicines European public assessment report (EPAR): Aqumeldi, enalapril maleate, Date of authorisation: 15/11/2023, Revision: 2, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Nucala, Mepolizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immune system disorders, PIP number: P/0367/2024

Scientific recommendations on classification of advanced therapy medicinal products

European Platform for Regulatory Science Research meeting September 2025 , Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 September 2025, 14:00 (CEST) to 29 September 2025, 17:30 (CEST)

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Date of authorisation: 20/09/2006, Revision: 52, Status: Authorised